A Study of SI-6603 in Patients With Lumbar Disc Herniation
Public ClinicalTrials.gov record NCT02421601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Study of SI 6603 in Patients With Lumbar Disc Herniation (Phase III)
Study identification
- NCT ID
- NCT02421601
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Seikagaku Corporation
- Industry
- Enrollment
- 1,011 participants
Conditions and interventions
Conditions
Interventions
- Condoliase Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2015
- Primary completion
- Jan 31, 2018
- Completion
- Jan 31, 2018
- Last update posted
- Mar 22, 2023
2015 – 2018
United States locations
- U.S. sites
- 30
- U.S. states
- 15
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Gold River | California | — | — |
| Not listed | Laguna Hills | California | — | — |
| Not listed | Los Gatos | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | Temecula | California | — | — |
| Not listed | Greenwood Village | Colorado | — | — |
| Not listed | Clermont | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miami Gardens | Florida | — | — |
| Not listed | Naples | Florida | — | — |
| Not listed | Pinellas Park | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | South Miami | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Newnan | Georgia | — | — |
| Not listed | Bloomington | Illinois | — | — |
| Not listed | Carmel | Indiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | City of Saint Peters | Missouri | — | — |
| Not listed | Hartsdale | New York | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Sandy City | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02421601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2023 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02421601 live on ClinicalTrials.gov.